Radioactive 'Bullets' target ovarian cancer in early trial
NCT ID NCT03732768
First seen Apr 18, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This early-phase study tested a new treatment called Radspherin® in 21 people with recurrent ovarian cancer that had spread in the abdomen. The treatment involves injecting tiny radioactive particles directly into the belly after surgery to remove visible tumors. The main goals were to find a safe dose and check for side effects, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clínica Universidad de Navarra
Madrid, Spain
-
Clínica Universidad de Navarra
Pamplona, Spain
-
The Norwegian Radiumhospital
Oslo, Norway
-
UZ Leuven
Leuven, 3000, Belgium
Conditions
Explore the condition pages connected to this study.